Chimera is a GLP/GCP certified bioanalytical CRO and immunoassay platform provider specialized in ultra sensitive large-molecule bioanalysis, and the world’s leading Immuno-PCR based technology vendor.
Beginning with the proprietary Imperacer® (Immuno-PCR) platform, which combines immunoassay specificity with an exponential PCR read-out, Chimera offers services on several highly sensitive platforms that go beyond the capabilities of conventional ELISA, and is constantly evaluating emerging bioanalytical platforms to extend expertise and platform portfolio to deliver immunoassay performance exceeding the highest expectations.
Since 2000, Chimera is supporting drug development programs with the greatest demands on sensitivity and bioanalytical quality. A Ph.D level project manager will be the key contact person to ensure that Chimera’s dedicated team of scientists is working to fulfill study requirements with the highest quality and swift turnaround.